Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa™ Versus Individual Administration of Each Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

793

Participants

Timeline

Start Date

August 1, 2007

Primary Completion Date

May 26, 2008

Study Completion Date

October 27, 2008

Conditions
Infections, Meningococcal
Interventions
BIOLOGICAL

Meningococcal vaccine GSK134612

Single dose intramuscular injection

BIOLOGICAL

Infanrix™ hexa

Single dose intramuscular injection

BIOLOGICAL

Meningitec™

Single dose intramuscular injection

Trial Locations (89)

10315

GSK Investigational Site, Berlin

10627

GSK Investigational Site, Berlin

11527

GSK Investigational Site, Athens

12627

GSK Investigational Site, Berlin

12679

GSK Investigational Site, Berlin

13055

GSK Investigational Site, Berlin

13355

GSK Investigational Site, Berlin

13507

GSK Investigational Site, Berlin

14197

GSK Investigational Site, Berlin

18059

GSK Investigational Site, Rostock

22089

GSK Investigational Site, Hamburg

22307

GSK Investigational Site, Hamburg

24534

GSK Investigational Site, Neumünster

24937

GSK Investigational Site, Flensburg

24944

GSK Investigational Site, Flensburg

24955

GSK Investigational Site, Harrislee

25813

GSK Investigational Site, Husum

25899

GSK Investigational Site, Niebüll

27793

GSK Investigational Site, Wildeshausen

32339

GSK Investigational Site, Espelkamp

32427

GSK Investigational Site, Minden

32457

GSK Investigational Site, Porta Westfalica

32479

GSK Investigational Site, Hille

32549

GSK Investigational Site, Bad Oeynhausen

32584

GSK Investigational Site, Löhne

32756

GSK Investigational Site, Detmold

33332

GSK Investigational Site, Gütersloh

34225

GSK Investigational Site, Braunatal

37269

GSK Investigational Site, Eschwege

38226

GSK Investigational Site, Salzgitter

40699

GSK Investigational Site, Erkrath

41061

GSK Investigational Site, Mönchengladbach

41749

GSK Investigational Site, Viersen

42551

GSK Investigational Site, Velbert

42579

GSK Investigational Site, Heiligenhaus

42719

GSK Investigational Site, Solingen

43100

GSK Investigational Site, Karditsa

44329

GSK Investigational Site, Dortmund

44379

GSK Investigational Site, Dortmund

44791

GSK Investigational Site, Bochum

45711

GSK Investigational Site, Datteln

47533

GSK Investigational Site, Kleve-Materborn

47574

GSK Investigational Site, Goch

47798

GSK Investigational Site, Krefeld

54290

GSK Investigational Site, Trier

54636

GSK Investigational Site, Thessaloniki

55131

GSK Investigational Site, Mainz

55239

GSK Investigational Site, Gau-Odernheim

55276

GSK Investigational Site, Oppenheim

58802

GSK Investigational Site, Balve

63110

GSK Investigational Site, Rodgau

63739

GSK Investigational Site, Aschaffenburg

65205

GSK Investigational Site, Wiesbaden

67227

GSK Investigational Site, Frankenthal

67346

GSK Investigational Site, Speyer

68167

GSK Investigational Site, Mannheim

68300

GSK Investigational Site, Didimoteicho

70469

GSK Investigational Site, Stuttgart

71672

GSK Investigational Site, Marbach

71720

GSK Investigational Site, Oberstenfeld

74072

GSK Investigational Site, Heilbronn

74357

GSK Investigational Site, Bönnigheim

74523

GSK Investigational Site, Schwäbisch Hall

75015

GSK Investigational Site, Bretten

75172

GSK Investigational Site, Pforzheim

76189

GSK Investigational Site, Karlsruhe

77704

GSK Investigational Site, Oberkirch

81241

GSK Investigational Site, Munich

81675

GSK Investigational Site, Munich

81735

GSK Investigational Site, Munich

82140

GSK Investigational Site, Olching

86720

GSK Investigational Site, Nördlingen

86916

GSK Investigational Site, Kaufering

87600

GSK Investigational Site, Kaufbeuren

88069

GSK Investigational Site, Tettnang

96317

GSK Investigational Site, Kronach

98724

GSK Investigational Site, Neuhaus am Rennweg

99425

GSK Investigational Site, Weimar

A-4070

GSK Investigational Site, Eferding

A 2491

GSK Investigational Site, Neufeld/Leitha

A-5020

GSK Investigational Site, Salzburg

A-9500

GSK Investigational Site, Villach

A-4600

GSK Investigational Site, Wels

09366

GSK Investigational Site, Stollberg

04808

GSK Investigational Site, Wurzen

07356

GSK Investigational Site, Bad Lobenstein

115 27

GSK Investigational Site, Athens

69 100

GSK Investigational Site, Komotini

591 00

GSK Investigational Site, Véria

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00508261 - Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa™ Versus Individual Administration of Each Vaccine | Biotech Hunter | Biotech Hunter